Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma
RSC Pharmaceutics · 2026 · 3 (3) · 630-644
DOI: 10.1039/d5pm00230c ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Zeina Kassem und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Pulmonary delivery of inhalable bispecific antibodies for the localised treatment of asthma.
Zitieren
APA
Kassem, Z., Lam, J. K. W., & Khalili, H. (2026). Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma. RSC Pharmaceutics, 3(3), 630-644. https://doi.org/10.1039/d5pm00230c
Vancouver
Kassem Z, Lam JKW, Khalili H. Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma. RSC Pharmaceutics. 2026;3(3):630-644. doi:10.1039/d5pm00230c
BibTeX
@article{Kassem2026,
author = {Kassem, Zeina and Lam, Jenny K. W. and Khalili, Hanieh},
title = {Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {3},
pages = {630--644},
doi = {10.1039/d5pm00230c}
}
EUVIMED